M. Meßner

发表

Design and synthesis of tailored human caseinolytic protease P inhibitors.

S. Sieber, Markus Lakemeyer, V. Korotkov, 2018, Chemical communications.

PI(18:1/18:1) is a SCD1-derived lipokine that limits stress signaling

M. Kwiatkowski, H. Schlüter, K. Rudolph, 2022, Nature Communications.

Different forms of streptolysin O produced by Streptococcus pyogenes and by Escherichia coli expressing recombinant toxin: cleavage by streptococcal cysteine protease

J. Musser, V. Kapur, S. Bhakdi, 1995, Infection and immunity.

Expression of active streptolysin O in Escherichia coli as a maltose-binding-protein--streptolysin-O fusion protein. The N-terminal 70 amino acids are not required for hemolytic activity.

S. Bhakdi, M. Palmer, J. Tranum-Jensen, 1996, European journal of biochemistry.

Small molecule inhibitors of the mitochondrial ClpXP protease possess cytostatic potential and re-sensitize chemo-resistant cancers

A. Vollmar, I. Jeremias, S. Sieber, 2021, Scientific Reports.

Inhibition of Cyclin‐Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy

S. Zahler, A. Vollmar, T. Lehr, 2018, Hepatology.

Metabolic implication of tigecycline as an efficacious second‐line treatment for sorafenib‐resistant hepatocellular carcinoma

A. Vollmar, H. Zischka, A. Gerbes, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma

K. Rudolph, K. Thedieck, A. Koeberle, 2020, Nature Communications.

Multi-feature clustering of CTCF binding creates robustness for loop extrusion blocking and Topologically Associating Domain boundaries

K. Rudolph, A. Papale, K. Thedieck, 2023, Nature communications.

Inhibition of Cyclin-dependent Kinase 5 – a Novel Strategy to Improve Sorafenib Response in HCC Therapy

Giorgio, S. Zahler, A. Vollmar, 2018 .

Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages.

S. Bhakdi, M. Klouche, M. Messner, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Immunohistochemical Demonstration of Enzymatically Modified Human LDL and Its Colocalization With the Terminal Complement Complex in the Early Atherosclerotic Lesion

H. Gabbert, S. Bhakdi, M. Klouche, 1998 .